Navigation Links
GenturaDx Appoints Senior Vice President of Research & Development
Date:7/11/2011

HAYWARD, Calif., July 11, 2011 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced today that Geoffrey A. McKinley, Ph.D., has joined the company as Senior Vice President of Research & Development.  McKinley joins as GenturaDx accelerates research to bring its IDbox™ System to commercialization.

(Photo:  http://photos.prnewswire.com/prnh/20110711/LA32940)

"With his depth of experience developing molecular diagnostic products, Geoff will be a key asset in commercializing our molecular platform in the next 12 to 24 months," said Mark Bagnall, GenturaDx's chief executive officer. "GenturaDx anticipates completing beta studies this year and clinical studies in 2012, and Geoff is an important addition to a talented R & D team working to perfect our system as well as develop partnerships with companies that seek to adapt assay content to our platform."

Dr. McKinley brings to GenturaDx nearly two decades of research & development and business development experience related to developing molecular diagnostic products and tools for infectious diseases.  Prior to joining GenturaDx, Dr. McKinley was responsible for research & development to support molecular biology assay, consumable and instrumentation development at Osmetech, Inc. He has previously held positions at Naxcor, Inc., BioMerieux, Inc., and Analytab Products, a division of Sherwood Medical. Dr. McKinley earned his Ph.D. at Colorado State University.

"It's a great time to be at GenturaDx," Dr. McKinley said, "because its unique, PCR-based, sample-to-answer IDbox System has the potential to dramatically impact molecular diagnostics, offering potential performance advantages over existing systems on the market and making the molecular testing affordable and easy to use for the estimated 5,000 small-to-medium sized hospitals that rely on traditional culture techniques or immunoassay testing."

About GenturaDx

GenturaDx is a molecular diagnostic company focused on making molecular diagnostics both affordable and practical for any laboratory to perform.  The company's IDbox System incorporates all aspects of proprietary, real-time PCR testing from sample preparation through result generation in a single-use cassette. This platform will make rapid, high-quality molecular diagnostics accessible to hospitals and patients worldwide – circumventing long-standing barriers of costs, automation and performance. GenturaDx's compact, self-contained platform reduces the risk of contamination and saves time; the platform's unique engineering design and intuitive interface relies on semi-batch processing capability while improving clinical value by offering multiple molecular targets in a single test.


'/>"/>
SOURCE GenturaDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... YORK , March 24, 2017 FinancialBuzz.com News ... Medical cannabis products ... View Research, Inc., projects that the global medical cannabis market will reach ... is a major market for the new growing industry. By ... place to legally buy and sell medical cannabis. More conservative states like ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports on four ... NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. (NYSE: EW), ... companies are part of the Healthcare sector, which gave back ... , 2017, with the NYSE Health Care Index declining 0.2% ... the S&P 500 were down about 0.4% as a group. ...
(Date:3/24/2017)... Wash. , March 23, 2017  Mirabilis ... of advanced medical technology for non-invasive surgery, announced ... Mirabilis System for treatment of uterine fibroids throughout ... it had received approval from the US Food ... of the Mirabilis System in the United States.  ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious ... to hospitals in the United States, it’s a threat that is constantly changing ... facing infection prevention and offers strategies for the healthcare community to help decrease ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... Southlake, Texas (PRWEB) , ... March 24, 2017 ... ... make 2017 the year of enhancements, upgrading their training and leads programs. , ... Empower University. Reserved for elite sales agents, Performance Partners is designed to teach ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The ... about real people of God in congregations across the United States. “The ... minister ordained in 1964 who has served congregations in seven states throughout his ...
Breaking Medicine News(10 mins):